OUR VISION FOR RESEARCH

Icon’s research team is essential to the evolution of healthcare, continuing to innovate and disrupt the way we manage and treat cancer. We aim to provide more patients with care opportunities previously not available to them by bringing tomorrow’s treatments closer to today.

With more than 35 years’ experience, research is part of Icon’s DNA. Our commitment is backed by international industry partnerships, investment in dedicated research teams and clinical leadership from highly respected researchers and specialists.

Icon’s international network of clinicians believe clinical trials are critical to the provision of exceptional cancer care and continue to confidently lead the way in operating Australia’s largest private cancer clinical trials program, with global growth opportunities.

Across Australia, New Zealand and Asia, Icon is dedicated to delivering the best care possible, to as many people as possible, as close to home as possible.

OVER 50 CANCER CENTRES GLOBALLY

730 360+

PATIENTS ACTIVE ON CLINICAL TRIALS

PATIENTS RECRUITED TO CLINICAL TRIALS / RESEARCH PROJECTS

Five cancer centres

Mainland China

Management service agreement

Vietnam

Two cancer centres

SINGAPORE

Three centres delivering research

Six cancer centres including flagship Mt Alvernia integrated centre Management of 70+ pharmacies

AUSTRALIA

Four TGA licensed compounding facilities Over 38 cancer centres

One cancer centre

One GMP licensed compounding facility

NEW

17 centres delivering research

Drug stability and research lab